The induction of CXCR4 expression in human osteoblast-like cells (MG63) by CoCr particles is regulated by the PLC-DAG-PKC pathway
Andreas Drynda
Department of Orthopaedic Surgery, Otto-von-Guericke University, Magdeburg, Germany
Search for more papers by this authorQiang Ren
Department of Orthopaedic Surgery, Otto-von-Guericke University, Magdeburg, Germany
Search for more papers by this authorGottfried H. Buchhorn
Department of Orthopaedics, University Medical Center, Göttingen, Germany
Search for more papers by this authorCorresponding Author
Christoph H. Lohmann
Department of Orthopaedic Surgery, Otto-von-Guericke University, Magdeburg, Germany
Correspondence to: C. H. Lohmann; e-mail: [email protected]Search for more papers by this authorAndreas Drynda
Department of Orthopaedic Surgery, Otto-von-Guericke University, Magdeburg, Germany
Search for more papers by this authorQiang Ren
Department of Orthopaedic Surgery, Otto-von-Guericke University, Magdeburg, Germany
Search for more papers by this authorGottfried H. Buchhorn
Department of Orthopaedics, University Medical Center, Göttingen, Germany
Search for more papers by this authorCorresponding Author
Christoph H. Lohmann
Department of Orthopaedic Surgery, Otto-von-Guericke University, Magdeburg, Germany
Correspondence to: C. H. Lohmann; e-mail: [email protected]Search for more papers by this authorAbstract
Background
Osteolysis which leads to aseptic loosening of implants is a fundamental problem in joint replacement surgery (arthroplasty) and the leading cause for implant failure and revision surgery. Metal (CoCr) particles separated from implants by wear cause osteolysis and the failure of orthopedic implants, but the molecular mechanism is not clear. The chemokine receptor CXCR4 has been shown to play a pivotal role in periprosthetic osteolysis. The aim of this study was to determine which signal transduction pathway (PLC-DAG-PKC or MAPK/ERK) induces CXCR4 expression in osteoblast-like cells (MG63) cells.
Methods
MG63 and Jurkat cells were stimulated with different amounts of particles (107, 106, and 105) for different time periods (30 min to 24 h), in the presence and absence of specific inhibitors (chelerythrine for the PLC-DAG-PKC pathway and PD98059 for the MAPK/ERK pathway). The expression of CXCR4-specific mRNA was determined by real-time polymerase chain reaction (PCR), and the PKC activity was measured by Western Blot using an antibody specific for PKC-related phosphorylation.
Results
Real-time PCR data showed that CXCR4 mRNA expression in MG63 cells induced by CoCr particles was significantly diminished by the PKC-specific inhibitor chelerythrine. This effect was not observed with the MAPK/ERK inhibitor PD98059. The involvement of PKC was also confirmed by an intensified phosphorylation pattern after stimulation with CoCr particles. In Jurkat cells, none of the inhibitors exhibited any effect.
Conclusion
The induction of CXCR4-specific mRNA expression in MG63 cells after stimulation with CoCr particles is regulated by the PLC-DAG-PKC pathway and not by the MAPK/ERK pathway. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 2326–2332, 2017.
REFERENCES
- 1Doorn PF, Campbell PA, Worrall J, Benya PD, McKellop HA, Amstutz HC. Metal wear particle characterization from metal on metal total hip replacements: Transmission electron microscopy study of periprosthetic tissues and isolated particles. J Biomed Mater Res 1998; 42: 103–111.
10.1002/(SICI)1097-4636(199810)42:1<103::AID-JBM13>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- 2Willert HG, Semlitsch M. Reactions of the articular capsule to wear products of artificial joint prostheses. J Biomed Mater Res 1977; 11: 157–164.
- 3Catelas I, Wimmer MA, Utzschneider S. Polyethylene and metal wear particles: Characteristics and biological effects. Semin Immunopathol 2011; 33: 257–271.
- 4Burton L, Paget D, Binder NB, Bohnert K, Nestor BJ, Sculco TP. Orthopedic wear debris mediated inflammatory osteolysis is mediated in part by NALP3 inflammasome activation. J Orthop Res 2013; 31: 73–80.
- 5Wang CT, Lin YT, Chiang BL, Lee SS, Hou SM. Over-expression of receptor activator of nuclear factor-kappaB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty. Biomaterials 2010; 31: 77–82.
- 6Romas E, Gillespie MT, Martin TJ. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 2002; 30: 340–346.
- 7Lau YS, Danks L, Sun SG, Fox S, Sabokbar A, Harris A, Athanasou NA. RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer. Breast Cancer Res Treat 2007; 105: 7–16.
- 8Shen Z, Crotti TN, McHugh KP, Matsuzaki K, Gravallese EM, Bierbaum BE, Goldring SR. The role played by cell-substrate interactions in the pathogenesis of osteoclast-mediated peri-implant osteolysis. Arthritis Res Ther 2006; 8: R70.
- 9Drynda A, Singh G, Buchhorn GH, Awiszus F, Ruetschi M, Feuerstein B, Kliche S, Lohmann CH. Metallic wear debris may regulate CXCR4 expression in vitro and in vivo. J Biomed Mater Res A 2015; 103: 1940–1948.
- 10Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A, Ratajczak J, Ratajczak MZ. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: Pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005; 23: 879–894.
- 11De Klerck B, Geboes L, Hatse S, Kelchtermans H, Meyvis Y, Vermeire K, Bridger G, Billiau A, Schols D, Matthys P. Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis. Arthritis Res Ther 2005; 7: R1208–R1220.
- 12Lohmann CH, Dean DD, Köster G, Casasola D, Buchhorn GH, Fink U, Schwartz Z, Boyan BD. Ceramic and PMMA particles differentially affect osteoblast phenotype. Biomaterials 2002; 23: 1855–1863.
- 13Kijima T, Maulik G, Ma PC, Tibaldi EV, Turner RE, Rollins B, Sattler M, Johnson BE, Salgia R. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res 2002; 62: 6304–6311.
- 14Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 2002; 62: 7203–7206.
- 15Busillo JM, Benovic JL. Regulation of CXCR4 signaling. Biochim Biophys Acta 2007; 1768: 952–963.
- 16Schwartz Z, Lohmann CH, Vocke AK, Sylvia VL, Cochran DL, Dean DD, Boyan BD. Osteoblast response to titanium surface roughness and 1alpha,25-(OH)(2)D(3) is mediated through the mitogen-activated protein kinase (MAPK) pathway. J Biomed Mater Res 2001; 56: 417–426.
10.1002/1097-4636(20010905)56:3<417::AID-JBM1111>3.0.CO;2-K CAS PubMed Web of Science® Google Scholar
- 17Buchhorn, GH, Willert HG, Semlitsch M, Schön S, Steinemann S, Schmidt M. Preparation, characterization, and animal testing for biocompatibility of metal particles of iron-, cobalt-, and titanium-based implant alloys. In: KRS John, editors. Particulate Debris from Medical Implants: Mechanisms of Formation and Histological Consequences. Philadelphia: ASTM STP; 1992. 1144: 177–188.
- 18Katzer A, Hockertz S, Buchhorn GH, Loehr JF. In vitro toxicity and mutagenicity of CoCrMo and TiAl wear particles. Toxicology 2003; 190: 145–154.
- 19Dean DD, Lohmann CH, Sylvia VL, Köster G, Liu Y, Schwartz Z, Boyan BD. Effect of polymer molecular weight and addition of calcium stearate on response to osteoblast-like cells to UHMWPE particles. J Orthop Res 2001; 19: 179–186.
- 20Herbert JM, Augereau JM, Gleye J, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1990; 172: 993–999.
- 21Cerioni L, Palomba L, Cantoni O. The Raf/MEK inhibitor PD98059 enhances ERK1/2 phosphorylation mediated by peroxynitrite via enforced mitochondrial formation of reactive oxygen species. FEBS Lett 2003; 547: 92–96.
- 22Schwartz Z, Lohmann CH, Sisk M, Cochran DL, Sylvia VL, Simpson J, Dean DD, Boyan BD. Local factor production by MG63 osteoblast-like cells in response to surface roughness and 1,25-(OH)2D3 is mediated via protein kinase C- and protein kinase A-dependent pathways. Biomaterials 2001; 22: 731–741.
- 23Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254.
- 24Lhotka C, Szekeres T, Steffan I, Zhuber K, Zweymuller K. Four-year study of cobalt and chromium blood levels in patients managed with two different metal-on-metal total hip replacements. J Orthop Res 2003; 21: 189–195.
- 25Back DL, Young DA, Shimmin AJ. How do serum cobalt and chromium levels change after metal-on-metal hip resurfacing? Clin Orthop Relat Res 2005; 438: 177–181.
- 26MacDonald SJ. Metal-on-metal total hip arthroplasty: The concerns. Clin Orthop Relat Res 2004: 86–93.
- 27Hallab NJ, Anderson S, Caicedo M, Skipor A, Campbell P, Jacobs JJ. Immune responses correlate with serum-metal in metal-on-metal hip arthroplasty. J Arthroplasty 2004; 8: 88–93.
- 28Niki Y, Matsumoto H, Otani T, Suda Y, Yatabe T, Yoshimine F, Kondo M, Toyama Y. Flow cytometric technique for the detection of phagocytosed wear particles in patients with total joint arthroplasty. Biomaterials 2003; 24: 3715–3724.
- 29Luo L, Petit A, Antoniou J, Zukor DJ, Huk OL, Liu RC, Winnik FM, Mwale F. Effect of cobalt and chromium ions on MMP-1, TIMP-1, and TNF-alpha gene expression in human U937 macrophages: A role for tyrosine kinases. Biomaterials 2005; 26: 5587–5593.
- 30Granchi D, Ciapetti G, Savarino L, Stea S, Filippini F, Sudanese A, Rotini R, Giunti A. Expression of the CD69 activation antigen on lymphocytes of patients with hip prosthesis. Biomaterials 2000; 21: 2059–2065.
- 31Hirbe AC, Rubin J, Uluckan O, Morgan EA, Eagleton MC, Prior JL, Piwnica-Worms D, Weilbaecher KN. Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone. Proc Natl Acad Sci USA 2007; 104: 14062–14067.
- 32Nagasawa T. A chemokine PBSF/SDF-1 and its receptor CXCR4: Function and involvement in HIV-1 infection. Seikagaku 1997; 69: 1373–1378.
- 33Lohmann CH, Schwartz Z, Köster G, Jahn U, Buchhorn GH, MacDougall MJ, Casasola D, Liu Y, Sylvia VL, Dean DD, Boyan BD. Phagocytosis of wear debris by osteoblasts affects differentiation and local factor production in a manner dependent on particle composition. Biomaterials 2000; 21: 551–561.
- 34Wong D, Korz W. Translating an Antagonist of Chemokine Receptor CXCR4: From bench to bedside. Clin Cancer Res 2008; 14: 7975–7980.
- 35Siddhanti SR, Hartle JE 2nd, Quarles LD. Forskolin inhibits protein kinase C-induced mitogen activated protein kinase activity in MC3T3-E1 osteoblasts. Endocrinology 1995; 136: 4834–4841.
- 36Menon LG, Picinich S, Koneru R, Gao H, Lin SY, Koneru M, Mayer-Kuckuk P, Glod J, Banerjee D. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells 2007; 25: 520–528.
- 37Reiling N, Blumenthal A, Flad HD, Ernst M, Ehlers S. Mycobacteria-induced TNF-alpha and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity. J Immunol 2001; 167: 3339–3345.
- 38Banerjee A, Gugasyan R, McMahon M, Gerondakis S. Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells. Proc Natl Acad Sci USA 2006; 103: 3274–3279.
- 39Fleury C, Petit A, Mwale F, Antoniou J, Zukor DJ, Tabrizian M, Huk OL. Effect of cobalt and chromium ions on human MG-63 osteoblasts in vitro: Morphology, cytotoxicity, and oxidative stress. Biomaterials 2006; 27: 3351–3360.
- 40Park BG, Yoo CI, Kim HT, Kwon CH, Kim YK. Role of mitogen-activated protein kinases in hydrogen peroxide-induced cell death in osteoblastic cells. Toxicology 2005; 215: 115–125.
- 41Bai XC, Lu D, Bai J, Zheng H, Ke ZY, Li XM, Luo SQ. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun 2004; 314: 197–207.
- 42Scapin G. Structural biology in drug design: Selective protein kinase inhibitors. Drug Discov Today 2002; 7: 601–611.
- 43Lohmann CH, Singh G, Willert HG, Buchhorn GH. Metallic debris from metal-on-metal total hip arthroplasty regulates periprosthetic tissues. World J Orthop 2014; 5: 660–666.
- 44Willert HG, Buchhorn GH, Fayyazi A, Flury R, Windler M, Koster G, Lohmann CH. Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints. A clinical and histomorphological study. J Bone Joint Surg Am 2005; 87: 28–36.
- 45Hart AJ, Hester T, Sinclair K, Powell JJ, Goodship AE, Pele L, Fersht NL, Skinner J. The association between metal ions from hip resurfacing and reduced T-cell counts. J Bone Joint Surg Br 2006; 88: 449–454.
- 46Granchi D, Savarino L, Ciapetti G, Cenni E, Rotini R, Mieti M, Baldini N, Giunti A. Immunological changes in patients with primary osteoarthritis of the hip after total joint replacement. J Bone Joint Surg Br 2003; 85: 758–764.
- 47Hallab NJ, Mikecz K, Vermes C, Skipor A, Jacobs JJ. Orthopaedic implant related metal toxicity in terms of human lymphocyte reactivity to metal-protein complexes produced from cobalt-base and titanium-base implant alloy degradation. Mol Cell Biochem 2001; 222: 127–136.